Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016–2018

por Buziashvili, Mariana, Davtyan, Hayk, Sereda, Yuliia, Denisiuk, Olga, Gozalov, Ogtay, Lomtadze, Nino, Hovhannesyan, Arax
Publicado 2021

Long-term Follow-up Reveals High Posttreatment Mortality Rate Among Patients With Extensively Drug-Resistant Tuberculosis in the Country of Georgia

por Frank, Melanie, Adamashvili, Natalia, Lomtadze, Nino, Kokhreidze, Eka, Avaliani, Zaza, Kempker, Russell R, Blumberg, Henry M
Publicado 2019

Hepatitis C Virus Co-Infection Increases the Risk of Anti-Tuberculosis Drug-Induced Hepatotoxicity among Patients with Pulmonary Tuberculosis

por Lomtadze, Nino, Kupreishvili, Lali, Salakaia, Archil, Vashakidze, Sergo, Sharvadze, Lali, Kempker, Russell R., Magee, Matthew J., del Rio, Carlos, Blumberg, Henry M.
Publicado 2013

HIV co-infection increases the risk of post-tuberculosis mortality among patients treated for drug resistant tuberculosis

por Salindri, Argita D., Kipiani, Maia, Lomtadze, Nino, Tukvadze, Nestani, Avaliani, Zaza, Blumberg, Henry M., Masyn, Katherine E., Rothenberg, Richard B., Kempker, Russell R., Magee, Matthew J.
Publicado 2023

Tuberculosis recovery in Georgia: implementing more by 24

por Kiria, Nana, Lomtadze, Nino, Solomonia, Nelly, Aspindzelashvili, Rusudan, Danelia, Maka, Gabisonia, Irakli, Janjgava, Marina, Khonelidze, Irma, Kipiani, Maia, Tukvadze, Nestani, Blumberg, Henry M, Kempker, Russell R, Furin, Jennifer, Avaliani, Zaza
Publicado 2022

Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines

por Gomez, Gabriela Beatriz, Siapka, Mariana, Conradie, Francesca, Ndjeka, Norbert, Garfin, Anna Marie Celina, Lomtadze, Nino, Avaliani, Zaza, Kiria, Nana, Malhotra, Shelly, Cook-Scalise, Sarah, Juneja, Sandeep, Everitt, Daniel, Spigelman, Melvin, Vassall, Anna
Publicado 2021